853 related articles for article (PubMed ID: 18324353)
21. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.
Basnet P; Skalko-Basnet N
Molecules; 2011 Jun; 16(6):4567-98. PubMed ID: 21642934
[TBL] [Abstract][Full Text] [Related]
22. Antioxidant activity of different species and varieties of turmeric (Curcuma spp): Isolation of active compounds.
Akter J; Hossain MA; Takara K; Islam MZ; Hou DX
Comp Biochem Physiol C Toxicol Pharmacol; 2019 Jan; 215():9-17. PubMed ID: 30266519
[TBL] [Abstract][Full Text] [Related]
23. Curcumin and cancer: barriers to obtaining a health claim.
Devassy JG; Nwachukwu ID; Jones PJ
Nutr Rev; 2015 Mar; 73(3):155-65. PubMed ID: 26024538
[TBL] [Abstract][Full Text] [Related]
24. Oxidative metabolites of curcumin poison human type II topoisomerases.
Ketron AC; Gordon ON; Schneider C; Osheroff N
Biochemistry; 2013 Jan; 52(1):221-7. PubMed ID: 23253398
[TBL] [Abstract][Full Text] [Related]
25. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
26. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism.
Sandur SK; Pandey MK; Sung B; Ahn KS; Murakami A; Sethi G; Limtrakul P; Badmaev V; Aggarwal BB
Carcinogenesis; 2007 Aug; 28(8):1765-73. PubMed ID: 17522064
[TBL] [Abstract][Full Text] [Related]
27. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.
Wilken R; Veena MS; Wang MB; Srivatsan ES
Mol Cancer; 2011 Feb; 10():12. PubMed ID: 21299897
[TBL] [Abstract][Full Text] [Related]
28. Turmeric: A condiment, cosmetic and cure.
Gopinath H; Karthikeyan K
Indian J Dermatol Venereol Leprol; 2018; 84(1):16-21. PubMed ID: 29243674
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids.
Messner DJ; Surrago C; Fiordalisi C; Chung WY; Kowdley KV
Biometals; 2017 Oct; 30(5):699-708. PubMed ID: 28801864
[TBL] [Abstract][Full Text] [Related]
30. Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.
Chen J; Wang FL; Chen WD
Mol Biol Rep; 2014 Jul; 41(7):4583-94. PubMed ID: 24604727
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors.
Wan SB; Yang H; Zhou Z; Cui QC; Chen D; Kanwar J; Mohammad I; Dou QP; Chan TH
Int J Mol Med; 2010 Oct; 26(4):447-55. PubMed ID: 20818481
[TBL] [Abstract][Full Text] [Related]
32. Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.
Rahmani AH; Al Zohairy MA; Aly SM; Khan MA
Biomed Res Int; 2014; 2014():761608. PubMed ID: 25295272
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic Differences in the Inhibition of NF-κB by Turmeric and Its Curcuminoid Constituents.
Edwards RL; Luis PB; Nakashima F; Kunihiro AG; Presley SH; Funk JL; Schneider C
J Agric Food Chem; 2020 Jun; 68(22):6154-6160. PubMed ID: 32378408
[TBL] [Abstract][Full Text] [Related]
34. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review.
Hosseini A; Hosseinzadeh H
Biomed Pharmacother; 2018 Mar; 99():411-421. PubMed ID: 29367110
[TBL] [Abstract][Full Text] [Related]
35. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
36. Molecular understanding of curcumin in diabetic nephropathy.
Soetikno V; Suzuki K; Veeraveedu PT; Arumugam S; Lakshmanan AP; Sone H; Watanabe K
Drug Discov Today; 2013 Aug; 18(15-16):756-63. PubMed ID: 23651956
[TBL] [Abstract][Full Text] [Related]
37. Formulations of Curcumin Nanoparticles for Brain Diseases.
Del Prado-Audelo ML; Caballero-Florán IH; Meza-Toledo JA; Mendoza-Muñoz N; González-Torres M; Florán B; Cortés H; Leyva-Gómez G
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30743984
[TBL] [Abstract][Full Text] [Related]
38. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
39. Biological properties of metal complexes of curcumin.
Shakeri A; Panahi Y; Johnston TP; Sahebkar A
Biofactors; 2019 May; 45(3):304-317. PubMed ID: 31018024
[TBL] [Abstract][Full Text] [Related]
40. Curcuma as an adjuvant in colorectal cancer treatment.
Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
